Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (9)
  • 2025 (10)

Subject

  • Drug Trafficking (375)
  • OCDETF/Task Force (102)
  • Guns/Weapons (87)
  • Fake Pills (47)
  • Money Laundering (25)
  • Gangs (24)
  • HIDTA (17)
  • Prescription Drugs (14)
  • Counterfeit Pills (13)
  • Fentanyl Free America (13)
  • Synthetic drugs (9)
  • Fentanyl Awareness (6)
  • Major Law Enforcement Operation (6)
  • Outreach/Drug Prevention (6)
  • Take Back Day (6)
  • Arrests/Convictions - Major (5)
  • One Pill Can Kill (5)
  • Overdose (5)
  • Other (4)
  • Pharmaceuticals/Pharmacists/Physicians (4)
  • Task Forces/Task Force Officers (4)
  • Cartel (3)
  • Extraditions (3)
  • Press Conferences (3)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Seizures (Drugs/Property) (3)
  • Terrorism (3)
  • Campaigns (2)
  • International/Foreign Operations (2)
  • Narcoterrorism (2)
  • Prevention/Education - DEA websites GSAD, JTT etc (2)
  • Red Ribbon (2)
  • Intelligence Division - Intelligence Products (1)
  • Intergovernmental Affairs (1)
  • Museum and Visitors Center (1)
  • Diversion Division (19)

Drug Name

  • Fentanyl (4)
  • Benzodiazepines (3)
  • Amphetamines (2)
  • Cocaine (2)
  • Heroin (2)
  • Hydromorphone (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Methamphetamine (1)
  • Oxycodone (1)

Field Division

  • Atlanta (3)
  • Chicago (1)
  • Dallas (1)
  • El Paso (6)
  • Houston (5)
  • Los Angeles (2)
  • Louisville (1)
  • Miami (5)
  • New England (12)
  • New Jersey (3)
  • New Orleans (1)
  • New York (6)
  • Omaha (6)
  • Phoenix (2)
  • Rocky Mountain (2)
  • San Antonio (1)
  • San Francisco (7)
  • Seattle (8)
  • Sede (7)
  • St. Louis (8)
  • Tampa (1)
  • Washington, DC (4)
Clear All Results
View Archived Press Releases
19 Results - Showing 1 to 10
PRESS RELEASE

Pharmacist Charged With Drug Diversion From National Pharmacy Chain

BOSTON – A Pittsfield pharmacist has been charged in federal court in Boston with allegedly diverting Adderall and Dextroamp-amphetamin (generic Adderall) from a national pharmacy chain. Joshua Bradley, 30, of Pittsfield, was charged with five counts of acquiring a controlled substance by fraud, deception and subterfuge. The defendant will make...
PRESS RELEASE

Walmart Agrees to Pay $50 Million for Illegally Filling Unlawful Opioid Prescriptions

Washington, D.C. — The Justice Department, together with the Drug Enforcement Administration (DEA), today announced a $50 million settlement with Walmart Inc. (Walmart) to resolve allegations that Walmart pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act (CSA). “This...
PRESS RELEASE

Massachusetts Pharmacist Pleads Guilty to Diverting Controlled Substances

CONCORD, N.H. – Massachusetts pharmacist Rima Gerges-Maalouf, 60, pleaded guilty in Federal Court to diverting controlled prescription drugs while working as a pharmacist in New Hampshire, U.S. Attorney Erin Creegan announces. As set forth in the plea agreement, in August 2024, Gerges-Maalouf served as a per diem pharmacist at a...
PRESS RELEASE

Founder/CEO and Clinical President of Digital Health Company Sentenced for $90 Million Scheme to Distribute over 37 Million Pills of Adderall

Washington, D.C - The founder and former Chief Executive Officer (CEO) Ruthia He of Done Global Inc., a California-based digital mental health company, was sentenced today to six years in prison and a fine of $1 million for orchestrating a scheme that used her company’s technology platform, compensation structure, and...
PRESS RELEASE

Cheshire Nurse Who Illegally Distributed Controlled Substances is Sentenced

CHESHIRE, Conn. - David X. Sullivan, United States Attorney for the District of Connecticut, announced that MICHELE RENE MUZYKA, 61, of Cheshire, has been sentenced by U.S. District Judge Victor A. Bolden in New Haven to one day of imprisonment, time already served, and three years of supervised release, for...
PRESS RELEASE

Texas Doctor Convicted for Illegally Distributing More than a Million Pills

WASHINGTON D.C. - A federal jury in the Southern District of Texas convicted a Texas physician yesterday for unlawfully distributing more than a million pills of opioids and other dangerous controlled substances. “Medical physicians who exploit their prescribing authority for profit over patient care break an inherent trust with their...
PRESS RELEASE

DEA Operation Meltdown Shuts Down Hundreds of Illegal Online Pharmacies

WASHINGTON – Today, the U.S. Drug Enforcement Administration, with the cooperation of the U.S. Attorney’s Office for the Eastern District of New York, announced the seizure of more than 200 website domains tied to an India-based transnational criminal organization (TCO) working within the United States and allegedly responsible for at...
PRESS RELEASE

Cheshire Nurse Admits Illegally Distributing Controlled Substances

CHESHIRE, Conn. - David X. Sullivan, United States Attorney for the District of Connecticut, has announced that on January 21, 2026, MICHELE RENE MUZYKA, 61, of Cheshire, waived her right to be indicted and pleaded guilty before U.S. District Judge Victor A. Bolden in New Haven to an offense related...
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

Gang Member Sentenced to 5 Years in Federal Prison for Trafficking Narcotics in Southwestern Connecticut

BRIDGEPORT, Conn. - David X. Sullivan, United States Attorney for the District of Connecticut, announced that MODESTE ADODO, 29, was sentenced today by U.S. District Judge Michael P. Shea in Hartford to 60 months of imprisonment and three years of supervised release for trafficking narcotics. According to court documents and...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster